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Article focus
  To investigate an alternative option for 
anterior cruciate ligament (ACl) recon-
struction that overcomes certain limita-
tions of existing options.
  To identify the mechanical properties of 
varying diameters of decellularized por-
cine superflexor tendon (pSFT) graft.
  To stratify the mechanical profiles of vary-
ing diameters of pSFT graft to produce a 
range of options for differing patient 
requirements.
Key messages
  The required initial fixation stability can be 
successfully achieved with decellularized 
(pSFT) grafts using current market fixa-
tion devices.
  The mechanical properties of decellular-
ized pSFT grafts can be significantly 
stratifying the mechanical performance 
of a decellularized xenogeneic tendon 
graft for anterior cruciate ligament 
reconstruction as a function of graft 
diameter 
AN ANiMAl STudy
Objectives
This study investigated the biomechanical performance of decellularized porcine superflexor 
tendon (psFT) grafts of varying diameters when utilized in conjunction with contemporary 
AcL graft fixation systems. This aimed to produce a range of ‘off-the-shelf’ products with pre-
dictable mechanical performance, depending on the individual requirements of the patient.
Methods
Decellularized psFTs were prepared to create double-bundle grafts of 7 mm, 8 mm, and 9 
mm diameter. Femoral and tibial fixation systems were simulated utilizing Arthrex suspen-
sion devices and interference screws in bovine bone, respectively. Dynamic stiffness and 
creep were measured, followed by ramp to failure from which linear stiffness and load at 
failure were measured. The mechanisms of failure were also recorded.
Results
Dynamic stiffness was found to increase with greater graft diameter, with significant differ-
ences between all groups. conversely, dynamic creep reduced with increasing graft diam-
eter with significant differences between the 7 mm and 9 mm groups and the 8 mm and 9 
mm groups. significant differences were also found between the 7 mm, 8 mm, and 9 mm 
groups for linear stiffness, but no significant differences were found between groups for load 
at failure. The distribution of failure mechanisms was found to change with graft diameter.
Conclusion
This study showed that decellularized psFTs demonstrate comparable biomechanical prop-
erties to other AcL graft options and are a potentially viable option for AcL reconstruction. 
Although grafts can be stratified by their diameter to provide varying biomechanical prop-
erties, it may be more appropriate to alter the fixation technique to stratify for a greater 
diversity of biomechanical requirements.
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altered by varying graft diameter, and potentially by 
fixation method.
  This study demonstrates that decellularized pSFT 
grafts present a potentially viable option for ACl 
reconstruction from a biomechanical standpoint.
strengths and limitations
  This study demonstrated that different diameters of 
decellularized pSFT grafts could be reliably repro-
duced with predictable mechanical properties.
  The mechanical properties of the grafts were compa-
rable to conventional graft options.
  Further research to explore the effect of differing fixa-
tion devices on graft properties is needed.
introduction
Rupture of the anterior cruciate ligament (ACl) is a com-
mon injury affecting young and active people, in particu-
lar sports men and women.1 Estimates of the annual 
incidence of ACl injuries range from 32 to 80 per 
100 000,2 and the number of ACl reconstruction proce-
dures performed yearly has increased, rising from 32.9 to 
43.5 per 100 000 in the united States between 1994 and 
2006. This equates to nearly 130 000 procedures per 
year,3 with recent estimates as high as 300 000 recon-
structions per year.4 in the united kingdom, approxi-
mately 14 000 ACl reconstructions are performed each 
year.5 Studies have shown an association between 
untreated ACl injuries and subsequent meniscal damage 
and development of degenerative changes within the 
knee,6 all of which serve to highlight the growing burden 
facing orthopaedic surgeons and health services in 
general.
Graft options include hamstring tendon or bone-
patella tendon-bone (BPTB) autograft, which are currently 
the most popular choice,7 cadaveric allograft tendons, or 
synthetic grafts. Autograft tissues have potential inherent 
drawbacks related to donor-site morbidity,8 limited 
donor-site options in revision cases, and potentially inad-
equate graft dimensions following harvest.9 A recent 
meta-analysis suggests that overall outcomes in revision 
ACl reconstructions were superior with autografts com-
pared with allografts.10 Both autologous and allogeneic 
grafts cannot maintain cell vitality and suffer progressive 
structural degradation. This is associated with a reduction 
in mechanical properties,11 as the rate of tissue degrada-
tion typically exceeds that of constructive remodelling.12,13 
Synthetic grafts are also a treatment option, but have 
fallen out of favour due to their wear characteristics, fail-
ure rate, and the resultant chronic synovitis that frequently 
occurs.14,15 Synthetic options also often fail to provide the 
multiscale hierarchical structure present in natural ten-
dons and ligaments, essential for directing appropriate 
cell behaviour.16 While there is a wealth of preclinical 
research into methods of biologically augmenting ACl 
reconstruction, such as utilizing platelet-rich plasma,17 a 
decellularized tendon/ligament graft has the potential to 
replace a ruptured native ACl with the possible advan-
tage of improved integration and ligamentization pro-
cesses when compared with current graft solutions.
decellularization processes have been developed 
that remove the majority of cellular material from tis-
sues to produce a sterile biological scaffold graft with 
well-preserved biomechanical properties.18 The aim is 
that the scaffolds initially provide biomechanical func-
tion to replace the damaged tissue while providing an 
attractive regenerative environment for endogenous 
cells to repopulate the scaffold and recapitulate the nat-
ural tissue.19 Previous investigations in our group have 
explored the use of porcine superflexor (flexor digito-
rum profundus) tendons (pSFTs), with a view to devel-
oping a decellularized biological scaffold for ACl 
reconstruction. These studies have extensively demon-
strated that the scaffold possesses the appropriate 
mechanical properties for an ACl graft,18,20-22 with sig-
nificantly reduced dNA content (> 99%) and α-Gal 
epitope levels,20 while also demonstrating retention of 
structural proteins, biocompatibility, and in vivo regen-
erative capacity.20
However, the mechanical performance of these bio-
logical scaffolds in conjunction with ACl graft fixation 
devices has not yet been investigated. Typically, a recon-
structed ACl is a structural system consisting of three 
engineering subsystems performing in unison: the femo-
ral fixation system, the ACl graft, and the tibial fixation 
system. until biological incorporation has been achieved, 
failure within such a structural system is most commonly 
expected at either fixation system location, as failure of 
the ACl graft in isolation requires substantially more 
force.23,24 in this study, we aimed to evaluate the mechan-
ical performance of such a whole structural system in 
vitro while varying the ACl graft (in this case, the decel-
lularized pSFT graft).
Moreover, we aimed to investigate whether decellu-
larized pSFTs could be manufactured to create a portfolio 
of ACl grafts with different diameters that, when com-
bined with ACl graft fixation devices, created structural 
systems that generate different mechanical properties 
(based on graft size) within a range suitable for ACl 
reconstruction. Specifically, the dynamic mechanical 
(dynamic stiffness and creep) and failure properties (fail-
ure load, linear stiffness, mechanisms of failure) were 
investigated. This could potentially stratify decellularized 
pSFTs into a range of graft sizes with predictable mechan-
ical performance when used with fixation devices, pro-
viding a selection of ‘off-the-shelf’ ACl graft options. 
These could then be matched to each individual patient's 
requirements based on anthropometric measurements 
such as height and weight, femoral or tibial dimensions, 
or desired sport/activity level.
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Materials and Methods
tissue sourcing and decellularization. A total of 18 pSFTs 
were obtained from four-month-old, large, white, female 
pigs weighing between 70 kg and 80 kg from a local abat-
toir (J Penny, leeds, united kingdom) within 24 hours of 
slaughter. Following removal, pSFTs were stored at -20°C 
with phosphate buffered saline (PBS)-soaked filter paper 
prior to decellularization. Specimens were decellularized 
using a previously established procedure.18,20 in brief, 
this consisted of multiple freeze-thaw cycles (× 3), anti-
biotic treatment (PBS containing vancomycin hydrochlo-
ride (Merck, Nottingham, united kingdom), gentamycin 
sulphate (Merck), and polymyxin B sulphate (Merck)), 
acetone washes (vWR, lutterworth, united kingdom), 
low concentration detergent (sodium dodecyl sulphate 
(SdS; Sigma, Gillingham, united kingdom), 0.1% w/v) 
washes and benzonase (Merck) treatment. The process 
also included protease inhibitor treatment (aprotinin; 
Nordic Pharma, Reading, united kingdom) and a 0.1% 
peracetic acid (Sigma) sterilization step in the final stages 
of the process.
Graft preparation and fixation. Following decellulariza-
tion, pSFTs were bisected with care along their long axis 
using a scalpel to produce two lengths of decellularized 
tendon, which were looped to form double bundle ACl 
grafts (Fig. 1). These were measured with digital cali-
pers and cut to produce 7 mm, 8 mm, and 9 mm diam-
eter grafts (n = 6 for each group). Graft diameters were 
confirmed using a graft sizing block (dePuy Synthes, 
Raynham, Massachusetts). The order of graft diameters 
produced was at random. Each graft was then looped 
through a Tightrope femoral fixation device (Arthrex, 
Naples, Florida) and the free ends were whip-stitched 
with #2 FiberWire (Arthrex).
Bone was sourced from the lateral femoral condyles of 
skeletally mature bovine femurs obtained from a local 
abattoir (J Penny). Blocks of bovine bone were cut to a 
uniform size (35 mm × 35 mm × 40 mm) using a custom-
made jig. Tunnels were drilled in the bone blocks to a 
diameter equal to the intended tendon graft diameter, 
and grafts were fixed in place using an Arthrex bioabsorb-
able interference screw (Arthrex), representing the tibial 
fixation subsystem of the reconstruction. Screw diame-
ters were downsized by 1 mm with respect to the graft/
tunnel diameter, as use of equal screw sizes was found to 
cause fracture of either the bone block or screw itself in 
two pilot constructs. Each graft was then fixed via the 
Tightrope to a steel block representing the femoral fixa-
tion subsystem of the reconstruction (Fig. 2a). Preparation 
and assembly of the ACl replacement model was per-
formed by a single surgically trained author to maintain 
consistency.
test protocols. Biomechanical testing was performed 
using an instron ElectroPuls E10,000 (instron, High 
Wycombe, united kingdom) incorporating a 1 kN load 
cell. ACl grafts and their fixation subsystems were 
attached in series to the testing machine using bespoke 
brackets (Fig. 2b). All grafts were preconditioned by load-
ing them between 5 N and 50 N using a sinusoidal wave 
form for 30 cycles at 0.5 Hz. immediately following this, 
dynamic testing was performed by sinusoidally loading 
grafts between 50 N and 250 N for 1000 cycles at 1 Hz 
to simulate dynamic physiological loading conditions. 
Similar dynamic loading protocols have been used previ-
ously by other authors.25-30 during this phase of the test-
ing, the dynamic stiffness (k* = Δ peak to peak applied 
load / Δ peak to peak induced extension) and maximum 
dynamic creep extension of all specimens within each 
graft diameter group were continuously recorded. Creep 
in this instance referred to whole system creep (including 
the fixation points and devices) with the point of graft 
entry into the bone tunnel marked with ink prior to test-
ing to ensure the recorded extension was in fact due to 
creep rather than graft slippage.
Following dynamic testing, failure testing was per-
formed by subjecting grafts and their fixation systems to 
an extension ramp to failure at 50 mm per minute, a rate 
consistent with other studies.31,32 This phase of testing 
allowed for calculation of the linear stiffness (slope of the 
linear region of the load-extension curve) and failure load 
for all graft diameters investigated. Furthermore, it 
allowed for determination of the mechanisms of failure of 
the whole structural systems involved for the three 
groups. While it may have been logical to examine the 
Fig. 1a  Fig. 1b  Fig. 1c
a) Porcine superflexor tendons are harvested and decellularized. b) They are split along their long axis. c) This yields two potential double bundle anterior cruci-
ate ligament grafts, which are trimmed down appropriately to the desired graft diameter.
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failure mechanisms of each of the engineering subsys-
tems in isolation, this approach has previously been per-
formed extensively.23-30 Examining the structural system 
as a whole would better inform on which of each engi-
neering subsystems are more likely to fail having varied 
the graft diameter. For both dynamic and failure testing, 
data were captured at a frequency of 0.1 Hz.
statistical analysis. For dynamic test parameters (dynamic 
stiffness and creep), variances between graft size groups 
were determined using a two-way analysis of variance 
(ANovA). Tukey’s significant difference test was used for 
post hoc evaluation. A p-value of < 0.05 was considered 
to be statistically significant.
For the failure test parameters calculated (linear stiff-
ness and load at failure), a one-way ANovA was per-
formed. Again, Tukey’s significant difference test was 
used for post hoc evaluation, with a p-value of < 0.05 con-
sidered to be statistically significant. The data associated 
with this paper (including raw data and results) are openly 
available from the university of leeds data Repository.33
Results
Dynamic testing. The dynamic stiffness responses for all 
three groups (7 mm, 8 mm, and 9 mm graft diameters) 
are presented in Figure 3a. dynamic stiffness was found 
to increase significantly with cycles elapsed. Significant 
differences were found between all groups tested. 
Following 1000 cycles of loading, dynamic stiffness 
means of 143.4 N/mm (95% confidence interval (Ci) 
137.9 to 149.0), 157.7 N/mm (95% Ci 144.9 to 170.4), 
and 175.2 N/mm (95% Ci 166.5 to 183.9) were found for 
7 mm, 8 mm, and 9 mm graft groups, respectively. No 
significant interaction was found between graft size and 
cycles elapsed.
The dynamic creep extension responses for all groups 
tested are presented in Figure 3b. dynamic creep was 
found to significantly increase with cycles elapsed. 
Significant differences were found between 7 mm and 9 
mm graft size groups, in addition to between 8 mm and 
9 mm graft size groups. dynamic creep means of 6.6 mm 
(95% Ci 5.9 to 7.3), 6.2 mm (95% Ci 5.6 to 6.9), and 5.8 
mm (95% Ci 5.3 to 6.3) were found following 1000 
cycles of loading for 7 mm, 8 mm, and 9 mm graft 
groups, respectively. Again, no significant interaction 
was found between graft size and cycles elapsed.
Failure testing. Following failure testing, significant 
differences were found between all groups for linear 
stiffness with means of 167.8 N/mm (95% Ci 162.8 to 
Decellularized
pSFT graft
Bovine bone block
Stainless steel block
Tightrope (Arthrex)
Interference
screw (Arthrex)
Fig. 2a  Fig. 2b
a) Schematic of fixation system used to model anterior cruciate ligament replacement with decellularized porcine superflexor tendon (pSFT) graft (Tightrope 
(Arthrex, Naples, Florida) femoral fixation, interference screw (Arthrex) tibial fixation). b) System when attached to instron Electropuls E10,000 (instron, High 
Wycombe, united kingdom) for biomechanical testing.
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172.8), 187.0 N/mm (95% Ci 170.3 to 203.7), and 216.3 
N/mm (95% Ci 203.9 to 228.7) for 7 mm, 8 mm, and 9 
mm graft groups, respectively (Fig. 4a). However, no sig-
nificant differences were found for failure load between 
7 mm, 8 mm, and 9 mm graft size groups (Fig. 4b), with 
means of 531.6 N (95% Ci 472.7 to 590.5), 604.1 N (95% 
Ci 420.8 to 787.5), and 628.0 N (95% Ci 555.5 to 700.4), 
respectively.
Mechanisms of failure were observed at each of the 
three engineering subsystems: Tightrope failure, pull-out 
at the interference screw interface, and failure of the 
grafts itself. The number and distribution of these failures 
within graft size groups is presented in Table i. Two of the 
7 mm grafts failed via ‘cheese-wiring’ of the Tightrope 
through the graft tissue, while all the remaining failures 
occurred at either of the fixation devices themselves: nine 
at the Tightrope, seven at the interference screw.
Discussion
The decellularization of xenogeneic tissues such as the 
pSFT offers a promising alternative solution for the recon-
struction of ruptured ACls, delivering immunologically 
safe biomaterials ‘off the shelf’ and in plentiful supply. it 
is important, however, that the biomechanical properties 
of these biological scaffolds are fully characterized to 
ensure satisfactory performance fit for clinical purpose. 
This study therefore aimed to assess decellularized pSFTs 
using an in vitro biomechanical model of ACl reconstruc-
tion simulating both femoral and tibial fixation subsys-
tems. Furthermore, three different graft sizes (7 mm, 8 
mm, and 9 mm diameters) were investigated with a view 
to creating whole structural systems of ACl reconstruc-
tion that result in mechanical performance distinct to 
each graft size, yet still within a range similar to native 
ACls. This could allow the targeting of specific patient 
populations with grafts to match their requirements.
Mean stiffness values for native ACl tissue range from 
130 N/mm to 300 N/mm,34 depending on the age35,36 
and sex37 of the donor.34 Mean stiffness values for ham-
string tendon and BPTB autografts are reported to be 
approximately 800 N/mm and 450 N/mm, respec-
tively.23,24 There is a deliberate overcompensation in bulk 
strength and stiffness with the use of these autografts to 
accommodate for their subsequent degradation after 
implantation due to necrosis. This overcompensation 
facilitates graft survival until remodelling and ligamentiza-
tion is achieved. However, it may lead to a mismatch in 
mechanical properties and performance at the time of 
implantation, as the stiffness of these autografts far 
exceeds that of the native ACl. This presents an opportu-
nity for decellularized biological scaffolds to better match 
native ACl properties due to potentially reduced necrosis 
and quicker incorporation, as non-viable cells have already 
been removed. When the decellularized pSFT grafts were 
utilized with conventional suspension devices and inter-
ference screws, both dynamic and linear mean stiffness 
values of these whole systems fell within the native ACl 
range regardless of graft diameter. This is a potential 
advantage over conventional autografts, as it is not clear 
what impact the implantation of a graft that is significantly 
stiffer than the native ACl has on the knee. This applies to 
both short-term recovery with respect to rehabilitation, 
and in the long term with potential development of oste-
oarthritis. in addition, creep and stiffness values varied 
significantly between graft diameters, and values were 
readily reproducible between different specimens of 
equal size. This confirms that the mechanical performance 
of decellularized pSFT grafts within a predetermined 
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a) dynamic stiffness and b) dynamic creep extension responses for 7 mm, 8 mm, and 9 mm diameter decellularized porcine superflexor tendon grafts with 
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fixation model could be modulated by altering the graft 
diameter.
A stratified approach such as this creates the potential 
for producing a range of graft options with variable prop-
erties once implanted, allowing customization for an 
individual patient. This stratification may be informed by 
anthropometric measurements or desired level of activ-
ity. Previous imaging-based studies have demonstrated 
significant variation between the native ACl insertion size 
and the cross-sectional area of potential graft donor ten-
dons,38 a mismatch issue that could be mitigated with a 
range of pSFT graft sizes available ‘off the shelf’. Although 
significant differences were found between groups of dif-
ferent graft size, the dynamic stiffness in particular 
remained within the lower end (< 180 N/mm) of the 
native ACl stiffness range (130 N/mm to 300 N/mm).34 
Therefore, variation of the engineering systems of fixation 
may serve as a better approach in attempting to stratify 
for a broader variety of patient populations. Grafts utiliz-
ing transfemoral pins, for example, have previously dem-
onstrated significantly less displacement than when 
using cortical suspension devices.30 utilizing interference 
screws at both femoral and tibial fixation locations may 
also achieve this as the effective graft length can be 
reduced, therefore increasing the stiffness.
Achieving adequate initial fixation stability at the 
femoral and tibial fixation locations is crucial to allow 
participation in modern rehabilitation protocols.23 This 
is important as, at the time of implantation and until 
biological incorporation has been achieved, the forces 
required to cause failure at the fixation system locations 
are typically much lower than those required to cause 
failure of the graft itself.23,24 In vivo simulations suggest 
normal daily activities such as level walking (during 
midstance in particular) or descending stairs exert a 
peak physiological load on the ACl of approximately 
300 N during hyperextension.34,39,40 it is therefore a 
requirement of any ACl graft under fixation to withstand 
load in excess of this peak physiological level at the point 
of implantation, to ensure fixation stability throughout 
the rehabilitation process. Quoted values for the mini-
mum acceptable initial failure load for a given graft option 
range in the literature from 248 N41 to 454 N.35
For existing autograft/allograft options combined with 
various fixation methods, mean ultimate failure loads 
ranged from 201 N to 930 N for quadrupled hamstring 
grafts, and from 215 N to 681 N for BPTB grafts.23,24 These 
fixation methods included various combinations of sus-
pensory devices, as well as metal and bioabsorbable 
interference screws. When compared with the maximum 
loads exerted on the ACl during physiological loading 
(taken as 300 N for reasons detailed above), the mean 
comparative failure loads of decellularized pSFT grafts 
under fixation were 532 N for 7 mm grafts, 604 N for 8 
mm grafts, and 628 N for 9 mm grafts, all exceeding the 
454 N quoted as the upper limit of the range of minimum 
acceptable initial ultimate failure load.35 Therefore, the 
required initial fixation stability can also be successfully 
achieved with decellularized pSFT grafts using current 
market fixation devices.
it is possible that alternative fixation devices may pro-
duce a greater level of initial fixation stability, as most fail-
ures occurred at the fixation devices themselves rather 
than at the decellularized pSFT graft tissue. only 2 of the 
18 grafts tested failed directly (due to Tightrope 
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a) linear stiffness and b) failure load values for 7 mm, 8 mm, and 9 mm diameter decellularized porcine superflexor tendon grafts with fixation systems fol-
lowing failure testing. values presented as mean and 95% confidence intervals (n = 6). *Statistically significant difference between groups (one-way analysis of 
variance with Tukey post hoc analysis; p < 0.05).
table i. Failure mechanisms observed for the decellularized porcine super-
flexor tendon grafts with fixation systems. The distribution of failure mecha-
nisms was found to vary between each graft size group
Failure mechanism 7 mm graft 8 mm graft 9 mm graft
Tightrope failure, n 1 3 5
Graft pull-out at screw 
interface, n
3 3 1
Graft failure, n 2 0 0
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‘cheese-wiring’ through the grafts), both of which were 7 
mm diameter specimens. This is in agreement with previ-
ous literature, which has shown that grafts measuring 8 
mm or more are associated with reduced failure rates.9 
The distribution of mechanisms of failure was observed 
to change with decellularized pSFT graft size (Table i). For 
7 mm diameter graft systems, failure of the suspension 
device occurred in only one case, with the remaining 
cases failing either due to pull-out at the screw interface 
(n = 3), or as mentioned previously, direct graft failure 
(n = 2). The 8 mm diameter graft systems failed equally at 
either the suspension device (n = 3) or screw interface 
(n = 3). The 9 mm graft systems failed predominately at 
the suspension device (n = 5), with only one screw inter-
face failure. The interaction between the three engineer-
ing subsystems within this model of ACl reconstruction 
is evidently complex. However, it appears that as graft 
size increases, the graft itself and the screw interface 
become more resistant to failure causing a greater pro-
portion of suspension device failures.
The pSFT tissue was selected as a potential graft choice 
as it can be routinely harvested at relatively low cost and 
the healthy tissue can be obtained from young donors of 
a predetermined age, species, and source. Such selection 
procedures may yield more consistent graft quality and 
therefore more predictable material properties than allo-
graft tissues. The macroscopic dimensions of the pSFT 
grafts are similar to the human hamstring tendons com-
monly used as an autograft in ACl reconstruction, allow-
ing for their use in conjunction with currently available 
fixation devices (in this instance, femoral suspension 
devices and interference screws).
There are a number of limitations to address in this 
study. First, test specimens were only implanted in bone 
on the tibial side of the construct, whereas the femoral 
side was represented with a stainless steel block. This 
may have affected the results, as any failure at the femoral 
side was inevitably due to device failure rather than at the 
graft-fixation interface. The use of bovine bone rather 
than cadaveric human bone could also have an impact 
due to the differences in density between the two tissues. 
indeed, the decision to downsize the interference screw 
by 1 mm with respect to the graft/tunnel diameter was in 
direct response to two pilot constructs that failed during 
assembly, likely due to the higher density of the bovine 
bone block. However, there have been other studies 
examining ACl graft fixation methods that have similarly 
utilized bovine tissue to model the human knee.42,43
A common criticism of biomechanical studies of ACl 
grafts relates to the uniaxial tensile tests that are per-
formed, which do not realistically reproduce the in vivo 
forces experienced by the ACl. in addition to enabling 
more direct comparisons between studies to be drawn, it 
is likely that the resultant ultimate failure loads recorded 
are an underestimate compared with those that would be 
produced in vivo, as the tensile force vector is in line with 
the femoral tunnel. This reduces the effect of shear forces 
that occur when the tunnel is oblique to the force vector, 
potentially altering the forces required to cause failure.23
Further research is required to understand the in vivo 
effects on implanted decellularized tissue in the context 
of ACl reconstruction. Such work would help ascertain 
the likely variation in biomechanical properties as the 
graft incorporates, as well as the effect of the host’s 
immune response on both the implanted graft tissue and 
the overall healing response. While the utility of a poten-
tial tissue for ligament reconstruction initially hinges on 
the tissue’s mechanical and material properties, the host 
tissue response and associated remodelling process will 
ultimately determine the success or failure of the implanted 
graft as a regenerative medicine solution.44
in conclusion, this study demonstrates that decellu-
larized pSFT grafts present a potentially viable option for 
ACl reconstruction from a biomechanical point of view, 
exhibiting comparable initial fixation stability to existing 
graft options at the point of implantation. The ability to 
alter the mechanical performance of the graft by adjust-
ing the graft diameter has also been demonstrated. 
Alteration of the fixation technique or device in tandem 
with graft diameter may provide opportunities to stratify 
for a greater diversity of biomechanical requirements.
decellularized pSFT grafts present several potential 
benefits over existing graft options, in particular the elim-
ination of donor site morbidity, low cost of production 
and storage, and a plentiful supply of base tissue. Further 
research is being conducted by our institution in the form 
of a large animal study to explore the in vivo response to 
decellularized pSFT tissue including local and systemic 
immunological effects, cell infiltration, neovasculariza-
tion, integration, and ex vivo biomechanical properties 
compared with allograft controls and native ACls.
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